SOUTH PLAINFIELD, N.J., May 21, 2025 /PRNewswire/ — Unicon Pharma, a leading provider of compliance, validation, and workforce solutions for the life sciences industry, is excited to announce a strategic partnership with VRR Life Sciences, a Bangalore, India-based leader in Computer System Validation (CSV) and regulatory technology services.
Operating under the unified brand VRR Life Sciences, a Unicon Company, this collaboration marks a significant milestone in Unicon’s strategy to deliver scalable, tech-enabled compliance solutions to pharmaceutical, biotech, and medical device clients across the United States. This partnership follows Unicon’s 2024 collaboration with CORE to enhance CQV services and aligns with its broader vision of building an integrated global platform for validation and regulatory excellence. By combining Unicon’s strong U.S. market presence with VRR’s extensive CSV expertise and offshore delivery model, the partnership aims to provide enhanced value through speed, cost-efficiency, and quality assurance.
“Our clients are operating in a time of regulatory transformation, with increasing expectations around data integrity, digital systems, and global compliance,” said Ravi Kollipara, CEO of Unicon Pharma. “With VRR Life Sciences joining our platform, we are not only expanding our technical depth—we are reinforcing our ability to deliver high-quality results at scale.”
With a proven track record of successful CSV and regulatory projects for multinational clients, VRR Life Sciences brings AI-driven tools, automation frameworks, and a scalable team of validation experts to the partnership. This collaboration also provides VRR with a strategic commercial entry into the U.S. market.
“Joining with Unicon allows us to bring our proven methods to new markets while aligning with a partner who shares our values and standards,” said Gireesh T., CEO of VRR Life Sciences. “It’s an important step forward for our team and the clients we’ll serve together.”
VRR Life Sciences, a Unicon Company, will focus on enterprise-level CSV projects, data integrity remediation, and IT compliance initiatives—helping life sciences organizations reduce risk, enhance quality, and accelerate delivery across the development lifecycle.
For more information, visit:
Unicon Pharma Inc – http://www.uniconpharma.com
VRR Life Sciences – http://www.vrrlifesciences.com
SOURCE Unicon Pharma Inc
Mr. Powell to oversee Longeveron’s partnering and international strategy efforts MIAMI, June 26, 2025 (GLOBE…
Physician and Republican leader voices concern over rising crime and strained social infrastructure in the…
Guidance also outlines metabolic evaluation – like Baylor Genetics’ unique Global MAPS® untargeted metabolite screen…
Aeroflow’s new philanthropic giving initiative includes bold financial and volunteer commitments to healthcare, housing, and…
CUPERTINO, Calif., June 26, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva”…
WEXFORD, Pa., June 26, 2025 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis”…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="176px" width="400px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="12px" width="12px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="400px" width="1000px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
